- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Towards ethical drug pricing: the European Orphan Genomic Therapies Fund ; day:24 ; month:4 ; year:2024 ; pages:1-5
Gene therapy ; (24.4.2024), 1-5
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41434-024-00452-2
- URN
-
urn:nbn:de:101:1-2407090943398.296027048394
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Risse, Johanna
- Krzemien, Merlin
- Schnalke, Jan
- Heinemann, Thomas
- SpringerLink (Online service)
Other Objects (12)
Variables affecting pricing of orphan drugs: the Italian case
African Orphan Crops Consortium (AOCC): status of developing genomic resources for African orphan crops
Genomic technologies—from tools to therapies
Pricing and reimbursement of orphan drugs: the need for more transparency
Shining a light in the black box of orphan drug pricing
Ethical considerations in prenatal genomic testing
Pricing sin stocks: Ethical preference vs. risk aversion
Pricing sin stocks: Ethical preference vs. risk aversion
Pricing Sin Stocks: Ethical Preference vs. Risk Aversion
Progressive Pricing: The Ethical Case for Price Personalization
Pricing sin stocks : ethical preference vs. risk aversion
Application of four pricing models for orphan medicines: a case study for lumasiran
Variables affecting pricing of orphan drugs: the Italian case
African Orphan Crops Consortium (AOCC): status of developing genomic resources for African orphan crops
Genomic technologies—from tools to therapies
Pricing and reimbursement of orphan drugs: the need for more transparency
Shining a light in the black box of orphan drug pricing
Ethical considerations in prenatal genomic testing
Pricing sin stocks: Ethical preference vs. risk aversion
Pricing sin stocks: Ethical preference vs. risk aversion
Pricing Sin Stocks: Ethical Preference vs. Risk Aversion
Progressive Pricing: The Ethical Case for Price Personalization
Pricing sin stocks : ethical preference vs. risk aversion
Application of four pricing models for orphan medicines: a case study for lumasiran
Variables affecting pricing of orphan drugs: the Italian case
African Orphan Crops Consortium (AOCC): status of developing genomic resources for African orphan crops
Genomic technologies—from tools to therapies
Pricing and reimbursement of orphan drugs: the need for more transparency
Shining a light in the black box of orphan drug pricing
Ethical considerations in prenatal genomic testing
Pricing sin stocks: Ethical preference vs. risk aversion
Pricing sin stocks: Ethical preference vs. risk aversion
Pricing Sin Stocks: Ethical Preference vs. Risk Aversion
Progressive Pricing: The Ethical Case for Price Personalization
Pricing sin stocks : ethical preference vs. risk aversion